Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895940251> ?p ?o ?g. }
- W2895940251 endingPage "96" @default.
- W2895940251 startingPage "86" @default.
- W2895940251 abstract "We conducted a 6-week double-blind, placebo-controlled, augmentation study comparing the efficacy and safety of MSI-195 800 mg (a proprietary formulation of S-adenosylmethionine) or placebo added to ongoing antidepressant medication (ADT) in acutely depressed subjects with Major Depressive Disorder (MDD) who had experienced an inadequate response to their ongoing ADT (The Horizon Study, ClinicalTrials.gov NCT01912196). There were 234 eligible subjects randomized to either MSI-195 (n = 118) or placebo (n = 116). There were no overall statistically significant differences found between MSI-195 added to ongoing ADT compared to placebo on any of 3 depression-rating instruments (HamD17, MADRS, IDS-SR30) in the ITT set. MSI-195 was generally safe and well tolerated with predominantly mild gastrointestinal side effects. Post-hoc analyses examined factors that might have affected study outcome. The ITT set was divided into subjects enrolled during the 1st half (first nine months) and 2nd half of the study. MSI-195 added to ongoing ADT was significantly better than placebo on both the HamD17 and MADRS in the 1st half (p = 0.03 and 0.02 respectively), but not in the 2nd half of the study. Several demographic and clinical characteristics were significantly different between the two study segments including body mass index, pre-randomization symptom severity fluctuation, number of lifetime depressive episodes, and anxious depression sub-type. Thus, the characteristics of the enrolled subjects changed between the 1st and 2nd half of the study. These post-hoc findings highlight the inherent challenges encountered for subject selection in double-blind, placebo controlled trials and compel further investigation of enrollment criteria and moderating factors that affect treatment. The favorable safety profile and clinical benefit observed with MSI-195 in the 1st half of this study warrant further investigation in MDD." @default.
- W2895940251 created "2018-10-26" @default.
- W2895940251 creator A5037318987 @default.
- W2895940251 creator A5065062150 @default.
- W2895940251 creator A5071455209 @default.
- W2895940251 creator A5083476984 @default.
- W2895940251 date "2018-12-01" @default.
- W2895940251 modified "2023-10-18" @default.
- W2895940251 title "An augmentation study of MSI-195 (S-adenosylmethionine) in Major Depressive Disorder" @default.
- W2895940251 cites W1964368905 @default.
- W2895940251 cites W1974098282 @default.
- W2895940251 cites W1975588273 @default.
- W2895940251 cites W1979344515 @default.
- W2895940251 cites W1979604894 @default.
- W2895940251 cites W1983284282 @default.
- W2895940251 cites W1996454121 @default.
- W2895940251 cites W2003804399 @default.
- W2895940251 cites W2003829093 @default.
- W2895940251 cites W2007585855 @default.
- W2895940251 cites W2017435851 @default.
- W2895940251 cites W2020739757 @default.
- W2895940251 cites W2022673879 @default.
- W2895940251 cites W2023619468 @default.
- W2895940251 cites W2026923692 @default.
- W2895940251 cites W2027865311 @default.
- W2895940251 cites W2031831813 @default.
- W2895940251 cites W2039432108 @default.
- W2895940251 cites W2039997546 @default.
- W2895940251 cites W2041904882 @default.
- W2895940251 cites W2045106443 @default.
- W2895940251 cites W2048610900 @default.
- W2895940251 cites W2051180837 @default.
- W2895940251 cites W2058086036 @default.
- W2895940251 cites W2061252706 @default.
- W2895940251 cites W2063900798 @default.
- W2895940251 cites W2066834831 @default.
- W2895940251 cites W2069288238 @default.
- W2895940251 cites W2069864357 @default.
- W2895940251 cites W2070678460 @default.
- W2895940251 cites W2070828096 @default.
- W2895940251 cites W2073526412 @default.
- W2895940251 cites W2073912822 @default.
- W2895940251 cites W2087912588 @default.
- W2895940251 cites W2088807767 @default.
- W2895940251 cites W2090408573 @default.
- W2895940251 cites W2104518967 @default.
- W2895940251 cites W2111663098 @default.
- W2895940251 cites W2118181979 @default.
- W2895940251 cites W2120140544 @default.
- W2895940251 cites W2124788972 @default.
- W2895940251 cites W2131823335 @default.
- W2895940251 cites W2132324173 @default.
- W2895940251 cites W2133099789 @default.
- W2895940251 cites W2134564898 @default.
- W2895940251 cites W2136272373 @default.
- W2895940251 cites W2140725933 @default.
- W2895940251 cites W2142188404 @default.
- W2895940251 cites W2146659162 @default.
- W2895940251 cites W2147111327 @default.
- W2895940251 cites W2148083007 @default.
- W2895940251 cites W2148892068 @default.
- W2895940251 cites W2153403353 @default.
- W2895940251 cites W2161143338 @default.
- W2895940251 cites W2162856122 @default.
- W2895940251 cites W2164759779 @default.
- W2895940251 cites W2166379049 @default.
- W2895940251 cites W2237079496 @default.
- W2895940251 cites W2269913603 @default.
- W2895940251 cites W2291361311 @default.
- W2895940251 cites W2298299786 @default.
- W2895940251 cites W2315712791 @default.
- W2895940251 cites W2316471784 @default.
- W2895940251 cites W2325561684 @default.
- W2895940251 cites W2399110179 @default.
- W2895940251 cites W2561937053 @default.
- W2895940251 cites W2566453300 @default.
- W2895940251 cites W2733403941 @default.
- W2895940251 cites W2738035635 @default.
- W2895940251 cites W2751062015 @default.
- W2895940251 cites W4255162577 @default.
- W2895940251 doi "https://doi.org/10.1016/j.jpsychires.2018.10.010" @default.
- W2895940251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30368163" @default.
- W2895940251 hasPublicationYear "2018" @default.
- W2895940251 type Work @default.
- W2895940251 sameAs 2895940251 @default.
- W2895940251 citedByCount "12" @default.
- W2895940251 countsByYear W28959402512019 @default.
- W2895940251 countsByYear W28959402512020 @default.
- W2895940251 countsByYear W28959402512021 @default.
- W2895940251 countsByYear W28959402512022 @default.
- W2895940251 countsByYear W28959402512023 @default.
- W2895940251 crossrefType "journal-article" @default.
- W2895940251 hasAuthorship W2895940251A5037318987 @default.
- W2895940251 hasAuthorship W2895940251A5065062150 @default.
- W2895940251 hasAuthorship W2895940251A5071455209 @default.
- W2895940251 hasAuthorship W2895940251A5083476984 @default.
- W2895940251 hasConcept C118552586 @default.
- W2895940251 hasConcept C126322002 @default.